| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/1992 | CA2099121A1 Imino-2-polyfluoroalkyl-6-heterocyclylalkyl-3-benzothiazoline, their preparation and medications containing them |
| 07/03/1992 | CA2058593A1 Therapeutic benzazapine compounds |
| 07/03/1992 | CA2033509A1 Therapeutic cholesterol gallstone dissolution method |
| 07/01/1992 | EP0493378A1 Use of 2',3'-dideoxyguanosine for the treatment of AIDS |
| 07/01/1992 | EP0493362A2 Compositions and kits for the treatment of oral diseases |
| 07/01/1992 | EP0493346A2 Derivatives of 1,2,3,4-tetrahydronaphtylamine endowed with nootropic activity and pharmaceutical compositions containing same |
| 07/01/1992 | EP0493324A1 Certain (arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids and derivatives thereof |
| 07/01/1992 | EP0493064A1 Deacetylcolchicine derivatives |
| 07/01/1992 | EP0493048A1 The process for the preparation of enantiomerically pure thienopyran derivative |
| 07/01/1992 | EP0493041A2 Use of benzobicyclic carboxamides for the treatment of anxiety and migraine |
| 07/01/1992 | EP0493031A1 Dihydrobenzofuran carboxamides and process for their preparation |
| 07/01/1992 | EP0492997A1 Anticalculus oral composition |
| 07/01/1992 | EP0492930A2 Transdermal delivery of dobutamine |
| 07/01/1992 | EP0492904A1 Substituted benzene derivatives for use in the treatment of glaucoma |
| 07/01/1992 | EP0492903A1 Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma |
| 07/01/1992 | EP0492902A1 Substituted pyridine derivatives for use in the treatment of glaucoma |
| 07/01/1992 | EP0492841A1 Anti-herpes castanospermine esters |
| 07/01/1992 | EP0492747A2 Pharmaceutical preparation for topical application |
| 07/01/1992 | EP0492707A2 Hydrophilic form of perfluoro compounds and method of manufacture |
| 07/01/1992 | EP0492667A1 1,4-Benzothiazine-2-acetic acid derivatives, processes for production thereof and their use |
| 07/01/1992 | EP0492485A1 N-Acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 07/01/1992 | EP0492474A1 1,3-Dioxolane derivatives as cholesterol-lowering agents |
| 07/01/1992 | EP0492430A1 Oxetanocin derivative having imidazole base group |
| 07/01/1992 | EP0492391A2 Hair growth stimulator |
| 07/01/1992 | EP0492383A1 Use of heptastigmine in the therapy of cerebral ictus |
| 07/01/1992 | EP0492369A1 Novel amino and nitro containing tricyclic compounds useful as inhibitors of ace |
| 07/01/1992 | EP0492347A1 Process of preparation of threo-4-alkoxy-5-(arylhydroxymethyl)-2(5H)-furanones |
| 07/01/1992 | EP0492318A2 Agistatins, metabolites from Fusarium sp., process for their preparation and their use |
| 07/01/1992 | EP0492277A2 Cephalosporin derivatives |
| 07/01/1992 | EP0492257A1 Thiadiazinone derivatives |
| 07/01/1992 | EP0492249A1 Use of substituted 1,2,4-oxadiazole derivatives for controlling endoparasites, new 1,2,4-oxadiazole derivatives and process for their preparation |
| 07/01/1992 | EP0492247A1 Effervescent H2 blocker formulation |
| 07/01/1992 | EP0492235A1 Low moisture cholestyramine composition |
| 07/01/1992 | EP0492178A2 Naphthoic acid derivative |
| 07/01/1992 | EP0492164A1 Therapeutic agent for glaucoma containing 2-phenyl-3-oxo-2H-1,4-benzothiazine derivatives |
| 07/01/1992 | EP0492136A2 Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene |
| 07/01/1992 | EP0492105A2 Treatment of cardiac hypertrophy with angiotensin-II-receptor-blockers |
| 07/01/1992 | EP0492021A1 Use of certain 1,2-benzoisothiazol-3(2H)-1,1-dioxide derivatives in the treatment of depression and mania |
| 07/01/1992 | EP0492020A1 Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
| 07/01/1992 | EP0491956A1 Reveromycin a, production thereof, and antitumor drug and fungicide |
| 07/01/1992 | EP0491829A1 Method for immune system activation. |
| 07/01/1992 | EP0491797A1 Novel macrocyclic compounds and novel method of treatment |
| 07/01/1992 | EP0491793A1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
| 07/01/1992 | EP0491792A1 Methods of treating neurodegenerative conditions |
| 07/01/1992 | EP0491770A1 Substituted urea compounds and their preparation and use |
| 07/01/1992 | EP0491755A1 Gamma glutamyl transferases for treating diseases |
| 07/01/1992 | EP0491751A1 Antiviral tetrahydroimidazo 1,4]benzodiazepines |
| 07/01/1992 | EP0491709A1 2-substituted-1(4)-aryl piperazines and the process for their preparation |
| 07/01/1992 | EP0423318A4 Therapeutic cholesterol gallstone dissolution method |
| 07/01/1992 | EP0362270B1 Steroid lotion |
| 07/01/1992 | EP0308436B1 New medicated ointment, process for its production, means of application using said ointment and production of said ointment |
| 07/01/1992 | EP0256090B1 Solubilization of hydrophobic materials using lysophospholipid |
| 07/01/1992 | EP0196330B1 Use of pyrrothine derivatives |
| 07/01/1992 | EP0179858B1 Antacid composition |
| 07/01/1992 | CN1062353A Process for preparing aminoalkylketones derivatives and use in therapy |
| 07/01/1992 | CN1062350A Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
| 07/01/1992 | CN1062349A 3-substituted piperidine derivatives used in therapy |
| 07/01/1992 | CN1062294A Process for extracting crataegolic flavone from hawthorn leaves |
| 07/01/1992 | CN1062291A Pharmaceutical agents |
| 07/01/1992 | CN1062290A Low estrogen oral contraceptives |
| 07/01/1992 | CN1062289A Process for treating cardiovascular hypertrophy and hyperplasia |
| 07/01/1992 | CN1017245B Imidazolidinone compound and processes for preparation thereof |
| 07/01/1992 | CN1017244B Triazolyi quinoline derivatives |
| 07/01/1992 | CN1017242B New quianzoline derivatives and process for their production |
| 07/01/1992 | CA2058595A1 Acid-labile linker molecules |
| 07/01/1992 | CA2058563A1 4-(4-imidazolyl) piperidines substituted at position 1, their preparation and also their therapeutic applications |
| 07/01/1992 | CA2033483A1 Polyether antibiotic mi215-nf3 substance, production process thereof, and agent for control of chicken coccidiosis |
| 06/30/1992 | US5126506 2',3'-Dideoxy-2'-fluoronucleosides |
| 06/30/1992 | US5126488 2β,19-methyleneamino bridged steroids as aromatase inhibitors |
| 06/30/1992 | US5126445 Process for the preparation of cefodizime sodium |
| 06/30/1992 | US5126444 Intermediates for cephalosporin compounds |
| 06/30/1992 | US5126437 Aldophosphamide glycosides, a process for their preparation and their use as pharmaceutical active compounds |
| 06/30/1992 | US5126436 Antibiotics |
| 06/30/1992 | US5126376 Method for treating viral infection using topical administration |
| 06/30/1992 | US5126375 Asthma, chronic bronchitis |
| 06/30/1992 | US5126373 Composition for parenteral and oral nutrition |
| 06/30/1992 | US5126372 Excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives |
| 06/30/1992 | US5126371 Diarylacetylenes, their preparation and their use |
| 06/30/1992 | US5126368 Octenoic acid derivatives useful as thromboxane A2 inhibitors |
| 06/30/1992 | US5126365 Bicyclic derivatives |
| 06/30/1992 | US5126364 Antiemetics, antipsychotics |
| 06/30/1992 | US5126363 Central nervous system disorders |
| 06/30/1992 | US5126359 Fungicides |
| 06/30/1992 | US5126357 Anti-inflammatory picolyselenobenzamides and salts thereof |
| 06/30/1992 | US5126356 Antiischemic agents |
| 06/30/1992 | US5126354 Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivatives |
| 06/30/1992 | US5126353 Compositions and method of treating arrythmia with tetrahydropyridines |
| 06/30/1992 | US5126348 Nicotinic acid as vasodilator |
| 06/30/1992 | US5126347 Autoimmune deficiency syndrome |
| 06/30/1992 | US5126344 Diazine derivatives and pharmaceutical use |
| 06/30/1992 | US5126342 Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| 06/30/1992 | US5126341 Anti-inflammatory 1,8-naphthyridin-2-one derivatives |
| 06/30/1992 | US5126336 Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| 06/30/1992 | US5126331 Skin disorders |
| 06/30/1992 | US5126324 Method of enhancing growth in patients using combination therapy |
| 06/30/1992 | US5126148 Produced by human hematopoietic cells |
| 06/30/1992 | US5126145 Controlled release tablet containing water soluble medicament |
| 06/30/1992 | US5126144 Apparatus delivering nitroglycerin to the skin, process for the production thereof and use thereof |
| 06/30/1992 | US5126141 Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides |
| 06/30/1992 | US5126135 Dermatological composition based on an aqueous phase |